Endocarditis Caused by Staphylococcus aureus: A Reappraisal of the Epidemiologic, Clinical, and Pathologic Manifestations With Analysis of Factors Determining Outcome
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus is the leading cause of infectious endocarditis and its mortality has remained high despite better diagnostic and therapeutic procedures over time. We conducted a retrospective review of 133 cases of definite S. aureus endocarditis seen at a single tertiary care hospital over 22 years to assess changes in the epidemiology and incidence of the infection, manifestations, outcome, risk factors for mortality, and impact of cardiac surgery on prognosis.Patients were classified into 2 groups: 1) right-sided endocarditis (64 patients) and 2) left-sided endocarditis (69 patients). While the number of cases of left-sided endocarditis remained steady at 1-3 cases per 10,000 admissions, the incidence of right-sided endocarditis, after a peak in the early 1990s, declined to almost disappear in 2001. Among the cases of right-sided endocarditis, we found 2 subsets of patients with different clinical features and prognosis: the first subset comprised 53 intravenous drug abusers, and the second subset comprised 11 patients with catheter-associated S. aureus bacteremia and endocarditis. Fifty-one patients were human immunodeficiency virus (HIV)-positive drug abusers, most of whom (80.3%) had right-sided endocarditis. We did not find differences in mortality between HIV-positive and HIV-negative individuals; mortality seemed to depend more on the site of the heart involved than on HIV status.Among the cases of left-sided endocarditis, the mitral valve was more commonly involved than the aortic valve (61% vs. 30%). Overall, 74% of patients with left-sided endocarditis developed 1 or more cardiac or extracardiac complication. In comparison, only 23.4% of patients with right-sided endocarditis developed complications.Prosthetic valve endocarditis (PVE) was hospital-acquired more frequently than native valve endocarditis (NVE). Patients with PVE had a shorter duration of symptoms until diagnosis and presented with or developed cardiac murmurs less frequently than patients with NVE. Cardiac failure (49%), renal failure (43%) and central nervous system (CNS) events (35%) were frequently observed in patients with both PVE and NVE. Valve replacement was more frequently needed and more rapidly performed in patients with PVE than in their counterparts with NVE.The overall mortality of patients with right-sided endocarditis was 17%. While the mortality of right-sided endocarditis in injection drug users was 3.7%, the mortality of patients with right-sided endocarditis associated with infected intravenous catheters was 82% (odds ratio [OR], 0.01; 95% confidence interval [CI], 0.001-0.07). For left-sided endocarditis mortality was 38% and was not significantly different in patients with NVE or PVE (OR, 0.65; 95% CI, 0.23-1.87). CNS complications were associated with mortality in both NVE (OR, 6.55; 95% CI, 1.78-24.04) and PVE (OR, 32; 95% CI, 2.63-465.40). Development of 2 or 3 complications was associated with an increased risk of mortality (OR, 5.59; 95% CI, 1.08-28.80 and OR, 9.25; 95% CI, 1.36-62.72 for 2 vs. 1 complication and for 3 vs. 2 complications, respectively).Surgical treatment did not significantly influence mortality in cases of NVE, (OR, 3.19; 95% CI, 0.76-13.38) but significantly improved the prognosis of patients with PVE (OR, 69; 95% CI, 2.89-1647.18).S. aureus endocarditis is an aggressive, often fatal, infection. The results of the current study suggest that valve replacement will improve the outcome of infection, particularly in patients with PVE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 4×
“aureus is the second most common microorganism producing hospital-acquired bacteremia in hospitals in the United States.(205) It has been estimated that 1% of hospital stays involve a staphylococcal infection.”
BackgroundInfluentialProposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880
King, M. D., Humphrey, B. J., Wang, Y. F., Kourbatova, E. V., Ray, S. M., & Blumberg, H. M. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00005 · Cited by 776 · cited 1×
“In addition, the emergence and dissemination of methicillinresistant strains in the hospital setting, and more recently in the community, have led to the introduction of new antibiotics to counter these pathogens, which may change the prescription habits in the near future.(25,34,60,95,112,161) Recently, the American…”
BackgroundInfective Endocarditis: An Analysis Based on Strict Case Definitions
VON REYN, C. F., LEVY, B. S., ARBEIT, R. D., FRIEDLAND, G., & CRUMPACKER, C. S. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-4-505 · Cited by 775
Daniel, W. G., Mügge, A., Martin, R. P., Lindert, O., Hausmann, D., Nonnast-Daniel, B., Laas, J., & Lichtlen, P. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241203 · Cited by 723
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Persistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437
KORZENIOWSKI, O., & SANDE, M. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-4-496 · Cited by 355
LaPlante, K. L., & Rybak, M. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4665-4672.2004 · Cited by 284
Cherubin, C. E., & Sapira, J. D. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-10-199311150-00009 · Cited by 238
Infective Endocarditis Due to Staphylococcus aureus: Deleterious Effect of Anticoagulant Therapy
Tornos, P., Almirante, B., Mirabet, S., Permanyer, G., Pahissa, A., & Soler-Soler, J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.473 · Cited by 214 · cited 1×
“observations have been reported by another author, who suggested the deleterious effect of anticoagulant therapy in these patients.(180) Although most series have indicated a clear correlation between the demonstration of vegetations by TTE and a substantially higher incidence of systemic emboli, the presence of veget…”
ResultFowler, Jr., Sanders, L. L., Kong, L. K., McClelland, R. S., Gottlieb, G. S., Li, J., Ryan, T., Sexton, D. J., Roussakis, G., Harrell, L. J., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/515076 · Cited by 196 · cited 10×
“aureus endocarditis is frequently acquired during admission to the hospital.(50,56,57,63,69,149,176) As a matter of fact, the microbiology of PVE has changed as the result of infections acquired during hospital admissions, and S.”
BackgroundInfluentialRibera, E., Gomez-Jimenez, J., Cortes, E., del Valle, O., Planes, A., Gonzalez-Alujas, M. T., Almirante, B., Ocana, I., & Pahissa, A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-12-199612150-00005 · Cited by 187
Dworkin, R. J., Sande, M. A., Lee, B. L., & Chambers, H. F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91083-0 · Cited by 170 · cited 1×
“aureus endocarditis in drug addicts.(23,44,51,72) In addition, the emergence and dissemination of methicillinresistant strains in the hospital setting, and more recently in the community, have led to the introduction of new antibiotics to counter these pathogens, which may change the prescription habits in the near fu…”
BackgroundTransesophageal echocardiography in right-sided endocarditis
Román, J. S., Vilacosta, I., Zamorano, J., Almería, C., & Sánchez-Harguindey, L. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90250-5 · Cited by 162
Khatib, R., Saeed, S., Sharma, M., Riederer, K., Fakih, M. G., & Johnson, L. B. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0096-0 · Cited by 156 · cited 1×
“aureus bacteremia and endocarditis treated with vancomycin.(28,77,94,107,167) Although the reasons for this behavior of vancomycin are not entirely known, it has been shown that the concentrations of free vancomycin are significantly reduced when high concentrations of bacteria are present in the media.”
BackgroundStaphylococcus aureus Prosthetic Valve Endocarditis: Optimal Management and Risk Factors for Death
John, M. D. V., Hibberd, P. L., Karchmer, A. W., Sleeper, L. A., & Calderwood, S. B. (1998) · Clinical Infectious Diseases · doi:10.1086/516378 · Cited by 153 · cited 15×
“Valve replacement was more frequently needed and more rapidly performed in patients with PVE than in their counterparts with NVE.”
BackgroundResultInfluentialBayer, A. S. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.3.313 · Cited by 148
Nannini, E. C., Singh, K. V., & Murray, B. E. (2003) · Clinical Infectious Diseases · doi:10.1086/379021 · Cited by 103 · cited 1×
“However, comparative studies on the efficacy of these drugs have never been conducted, and only anecdotal case reports have suggested a lesser activity of cefazolin in staphylococcal endocarditis.(53,128) The combination of cell-wall active compound with gentamicin increases the bactericidal activity of the regimen an…”
Bayer, A. S. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370030061013 · Cited by 57
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60829-x · Cited by 504
Clinical presentation and treatment of orthopaedic implant‐associated infection
Zimmerli, W. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12233 · Cited by 481
Staphylococcus aureus Small‐Colony Variants Are Adapted Phenotypes for Intracellular Persistence
Tuchscherr, L., Heitmann, V., Hussain, M., Viemann, D., Roth, J., von Eiff, C., Peters, G., Becker, K., & Löffler, B. (2010) · The Journal of Infectious Diseases · doi:10.1086/656047 · Cited by 275
Clinical management of Staphylococcus aureus bacteraemia
Thwaites, G. E., Edgeworth, J. D., Gkrania-Klotsas, E., Kirby, A., Tilley, R., Török, M. E., Walker, S., Wertheim, H. F., Wilson, P., & Llewelyn, M. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70285-1 · Cited by 261
Metadata
- Authors
- Fernández Guerrero, M. L., González López, J. J., Goyenechea, A., Fraile, J., & de Górgolas, M.
- Venue
- Medicine
- Published
- 2009-01
- Volume
- 88
- Issue
- 1
- Pages
- 1-22
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W1990740789
- Cited by
- 121
- References
- 26
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.